As of 2:21pm ET
| +0.0202 / +1.15%|
The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +182.45% increase from the last price of 1.77.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.